Navigation Links
Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants
Date:7/23/2008

get in a patient after the transplant. Ultimately, our goal is to be able to use this technique to guide us in customizing the transplantation process to obtain better treatment results for patients."

The research involved 18 patients, ranging in age from 30 to 69 years who were diagnosed with various hematological cancers and serious blood disorders. They were followed by the research team for several years.

This research is funded by grants from the NIH and the Amy Strelzer Manasevit Research Program of the National Marrow Donor Program.

"The studies in stem cell transplantation being conducted at The Cancer Center help to contribute to very favorable outcomes rates for our Adult Blood and Marrow Stem Cell Transplantation Program," says Andrew L. Pecora, M.D., chairman and executive administrative director.

Each year between 80 and 100 patients undergo allogeneic stem cell transplantation at The Cancer Center at Hackensack University Medical Center. With the addition of autologous stem transplants, the program's experts perform more than 350 stem cell transplants every year, making it one of the 10 largest in the United States.

The Cancer Center is New Jersey's largest and the one ranked the best cancer center in the state by New York magazine. For more information about The Cancer Center, call (201) 996-5900 or visit http://www.humc.com.

Available Topic Experts: For information on the listed expert(s), click appropriate link.

Scott Rowley, M.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78490

Robert Korngold, Ph.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78622

Thea M. Friedman, Ph.D.


SOURCE The Cancer Center
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkins Lymphoma
2. DARPA awards research team $1.2M grant to study surface enhanced Raman scattering
3. Argonne researchers win 2 R&D 100 Awards
4. AMT Starts Collaboration With St. Jude Childrens Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
5. Worldwide Clinical Trials Emerges as Leading Global Contract Research Organization
6. Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
7. Research helps understand factors that influence efficiency of organic-based devices
8. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
9. Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2008 Winners Announced
10. Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties
11. Albany College of Pharmacy Researcher Receives $368,445 Grant from the National Institutes of Health

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ovember 5, 2009 at 4:30 p.m. Eastern Time , B...all/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex...d unaudited financial results for the third quarte...iewed the Company,s highlights for the third quart...ts reflect the operations of OncoGenex Technologie...
(Date:11/5/2009)...ewswire-FirstCall/ -- Wound Management Technologie...ed into a Letter of Intent to purchase all healthc... Inc. (OTC Bulletin Board: VHGI). The deal provide... 4,000,000 shares of WNDM and a royalty agreement ...chnology being acquired from VHGI. WNDM closed a...
(Date:11/5/2009).... 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Co..."Company") today announced,that the Company plans ...,Monday, November 9, 2009, after the market closes...ll at 5:00 pm ET on November 9, 2009,to discuss th...e call by,dialing 1-888-713-4211 or 1-617-213-4864...
(Date:11/4/2009)...ar, which will be presented on November 19 and is ...hemistry processing, will deal with the applicatio...so and micro scale flow chemistry equipment. Prof... recognized with several prestigious prizes and aw... Prize. , Columbia, MD (P...
Breaking Biology Technology:OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3BMP Sunstone to Report Third Quarter 2009 Financial Results 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
...ogress of Phase I Programme With Oral Iclaprim, "R...ctronic Submission of First Module... December 12 Arpida Ltd,(SWX: ARPN) announced tod...in the Phase II clinical study with intravenous ic...onia (HAP) / ventilator-associated pneumonia,(VAP)...
...KLAND, Calif., Dec. 12 LUMEDX Corporation, the ma...scular information and imaging,solutions, introduc...,cardiology software that translates complex data ...ble, actionable information. CardioManager,s,perfo...users with a,high-level view of data and the abili...
... AMES, Iowa Fuel-cell cars are reaching commercia...ociety, but despite their promise, even scientists... central component the proton exchange membrane ...at the U.S. Department of Energys Ames Laboratory ...lanation to date for the membranes structure and h...
Other Biology Technology:First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 2First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 3First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 4First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP 5New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance 2Ames Laboratory researchers solve fuel-cell membrane structure conundrum 2
(Date:11/4/2009)...stCall/ -- BIO-key International, Inc. (OTC Bullet...c identification software is showcasing donor and ...ence being held at the New Orleans Convention Cent...ands-on product demonstrations of its state-of-the..., at 5 PM on Monday, October 26, Peter Lux, manage...
(Date:11/4/2009)...ncoe Software, Inc., the commercial arm of the Ope...//openmicroscopy.org ), is proud to announce its ...ology,s exciting new project titled "The Cell: An ...stimulus grant through the National Institutes of ...t of the American Reinvestment and Recovery Act, t...
(Date:11/3/2009)...ublished in a recent issue of HortTechnology , sc...he effects of covering orchard floors with reflect...ght distribution, orchard temperature, and profita...day and Solarmate films installed 5 weeks before c...ples. The research showed that the use of both fil...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Reflective film can boost profits for apple growers 2Townhall Comes to Washington 3A FRC Action to Host Congressional Forum on Health Care 57410 1Townhall Comes to Washington 3A FRC Action to Host Congressional Forum on Health Care 57410 2AAHSA Statement on Senate Finance Committees Health Reform Bill 57406 1AAHSA Statement on Senate Finance Committees Health Reform Bill 57406 2Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 1Prescient Medical vProtect 28TM 29 Luminal Shield Receives North American Product Innovation of the Year Award from Frost 26 Sullivan 57403 2
... Purdue University and the University of Californi... may be more effective at cleansing itself of smog...ught. , Scientists, including Joseph S. Francisco...pheric chemicals react with sunlight more effectiv...that "scrub" the air of smog. This group of chemic...
...irologists headed by Professor Hans-Georg Kräussli...h Professor Hanswalter Zentgraf, Division of Appli...zentrum (German Cancer Research Center, DKFZ), hav...iruses (HIV) for visual investigations without inh...s. , The labeling permits scientists to observe t...
...ularly deadly form of skin cancer very resistant t...Center & Research Institute and the University...apy that prompts the immune system to aid in the f...ne clinical trial because it is the first time tha... DNA in a gene therapy study in humans," said Rich...
Other Biology News:Atmosphere may cleanse itself better than previously thought 2Atmosphere may cleanse itself better than previously thought 3Atmosphere may cleanse itself better than previously thought 4Virologists make major step towards understanding the process of HIV infection 2Researchers test new therapy for advanced melanoma 2
...rose and SYBR Safe DNA Gel Stain combo offers thes...ame products separately Offers a safer and be...es risks to yourself, the environment and your ins...om 100 bp to >30 kb. UltraPure Agarose is a standa...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...per liter of urine will give a positive reaction f...cation: The Donors are of US origin and have been...IV-1 & 2, Syphilis and HIV-1 Antigen by currently ...-VITRO DIAGNOSTIC USE ONLY IN MANUFACTURING OR RES...
Smarter Fermentation System Controller for One Vessel from Major Science
Biology Products: